US - CA - Fremont
January 6, 2025
Description • Ardelyx is a publicly traded commercial biopharmaceutical company founded with a mission to discover, develop and commercialize innovative first-in-class medicines that meet significant unmet medical needs. • Ardelyx has two commercial products approved in the United States, IBSRELA...
US - AZ - Phoenix
December 21, 2024
Description • Ardelyx is a publicly traded commercial biopharmaceutical company founded with a mission to discover, develop and commercialize innovative first-in-class medicines that meet significant unmet medical needs. • Ardelyx has two commercial products approved in the United States, IBSRELA...
US - AR - Little Rock
December 28, 2024
Description • Ardelyx is a publicly traded commercial biopharmaceutical company founded with a mission to discover, develop and commercialize innovative first-in-class medicines that meet significant unmet medical needs. Ardelyx has two commercial products approved in the United States, IBSRELA®...
US - MA - Waltham
January 9, 2025
Description • Ardelyx is a publicly traded commercial biopharmaceutical company founded with a mission to discover, develop and commercialize innovative first-in-class medicines that meet significant unmet medical needs. • Ardelyx has two commercial products approved in the United States,...
US - MA - Boston
December 2, 2024
Description • Ardelyx is a publicly traded commercial biopharmaceutical company founded with a mission to discover, develop and commercialize innovative first-in-class medicines that meet significant unmet medical needs. Ardelyx has two commercial products approved in the United States, IBSRELA®...